. Show Affiliations »
Abstract
Mesh： See more » Amphotericin B/administration & dosageAmphotericin B/adverse effectsAmphotericin B/toxicityAnorexia/chemically inducedAntifungal Agents/administration & dosageAntifungal Agents/therapeutic useAspergillosis/drug therapyBlastomycosis/drug therapyCandidiasis/drug therapyCoccidioidomycosis/drug therapyCryptococcosis/drug therapyCytochrome P-450 CYP3ACytochrome P-450 Enzyme InhibitorsDose-Response Relationship, DrugDrug InteractionsFluconazole/pharmacologyFlucytosine/toxicityGynecomastia/chemically inducedHistoplasmosis/drug therapyHumansItraconazole/adverse effectsItraconazole/bloodKetoconazole/adverse effectsKidney Diseases/chemically inducedLiposomesMaleMixed Function Oxygenases/antagonists & inhibitorsMucormycosis/drug therapyNausea/chemically inducedParacoccidioidomycosis/drug therapySporotrichosis/drug therapyTeratogens
Substances： See more » Antifungal AgentsCytochrome P-450 Enzyme InhibitorsLiposomesTeratogensItraconazoleAmphotericin BFluconazoleFlucytosineMixed Function OxygenasesCYP3A protein, humanCytochrome P-450 CYP3AKetoconazole
Year: 1997 PMID： 9305292
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN： 0025-732X Impact factor: 1.909